Disseminated Candidiasis Developing during Prophylaxis with Fluconazole in a Small-Intestine Transplant Recipient

Abstract

A 31-year-old man underwent immunosuppressive treatment and was treated with 150 mg per day of prophylactic oral fluconazole after receiving a small-intestine transplant. The patient had acute rejection by the end of the first week after the transplant. Endoscopic examination showed white plaques. In blood and urine cultures, growth of Candida albicans was detected. Biopsy specimens showed high levels of conidia and hyphae in all regions. Intravenous treatment with caspofungin was started for the patient. Candidal findings had regressed on follow-up endoscopy. However, the patient died 3 months after transplant because of the effects of immunosuppression on his bone marrow and the development of disseminated intravascular coagulation. Candida species are the most common cause of invasive fungal infections that develop after solid-organ transplant. Following transplant, candidemia may develop during systemic antifungal treatment with a high level of mortality.

Get full access to this article

View all access options for this article.

References

Fungal infections. Am J Transplant. 2004;4(suppl 10):110–134.

Pappas

Silveira

. Candida in solid organ transplant recipients. Am J Transplant. 2009;9(suppl 4):S173-S179.

Cole

Halawa

Anaissie

. The role of the gastrointestinal tract in hematogenous candidiasis: From the laboratory to the bedside. Clin Infect Dis. 1996;22(suppl 2): S73-S88.

Odds

. Candida infections: An overview. Crit Rev Microbiol. 1987;15(1):1–5.

Dongari-Bagtzoglou

Dwivedi

Ioannidou

Shaqman

Hull

Burleson

. Oral Candida infection and colonization in solid organ transplant recipients. Oral Microbiol Immunol. 2009;24(3):249–254.

Antoniewicz

Relijc

Poitschek

Presterl

Geusau

. Mucosal Candida infection and colonisation as well as associated risk factors in solid organ transplant recipients. Eur J Clin Microbiol Infect Dis. 2009;28(8):945–957.

Guaraldi

Cocchi

Codeluppi

. Outcome, incidence, and timing of infectious complications in small bowel and multivisceral organ transplantation patients. Transplantation. 2005;80(12):1742–1748.

Silveira

Husain

. Fungal infections in solid organ transplantation. Med Mycol 2007;45(4):305–320.

Patterson

. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis. 1999;1(4):229–236.

10.

Singh

. Fungal infections in the recipients of solid organ transplantation. Infect Dis Clin North Am. 2003;17(1):113–134, viii.

11.

Bonatti

Stelzmueller

Berger

. Infections caused by Candida krusei in five transplant and two surgical patients. Surg Infect (Larchmt). 2009;10(3):265–271.

12.

Kusne

Tobin

Pasculle

Van Thiel

Starzl

. Candida carriage in the alimentary tract of liver transplant candidates. Transplantation. 1994;57(3):398–402.

13.

Marr

Seidel

Slavin

. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: Long-term follow-up of a randomized, placebo-controlled trial. Blood. 2000;96(6):2055–2061.

14.

Marr

Seidel

White

Bowden

. Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole. J Infect Dis. 2000;181(1):309–316.

15.

Pappas

Alexander

Andes

. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50(8):1101–1111.

16.

Singh

. Changing spectrum of invasive candidiasis and its therapeutic implications. Clin Microbiol Infect. 2001;7 (suppl 2):1–7.

17.

Uzun

Ascioglu

Anaissie

Rex

. Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis. 2001;32(12):1713–1717.